Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells

British Journal of Haematology

Volumn 102, Issue 4, 1998, Pages 1090-1097

  Smith, Mitchell R ^a   Xie, Tao ^a   Joshi, Indira ^a   Schilder, Russell J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Glucocorticoids; Interleukin 6; Interleukin 6 receptor; Myeloma; Retinoic acid

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; RETINOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; HUMAN; HUMAN CELL; MYELOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; CELL DIVISION; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SYNERGISM; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; MULTIPLE MYELOMA; RECEPTORS, INTERLEUKIN-6; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031680637     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00850.x     Document Type: Article

References (51)

1. Alexanian, R., Barlogie, B. & Tucker, S. (1990) VAD-based regimens as primary treatment for multiple myeloma. American Journal of Hematology, 33, 86-89.
2. Alexanian, R. & Dimopoulos, M. (1994) The treatment of multiple myeloma. New England Journal of Medicine, 330, 484-489.
3. Alexanian, R., Dimopoulos, M.A., Delasalle, K. & Barlogie, B. (1992) Primary dexamethasone treatment of multiple myeloma. Blood, 80, 887-890.
4. Al-Katib, A., Mohammad, R., Hamdan, M., Mohamed, A.N., Dan, M. & Smith, M.R. (1993) Propagation of Waldenstrom's macroglobulinemia cells in vitro and in SCID mice: utility as a preclinical drug screening model. Blood, 81, 3034-3042.
5. Anderson, K.C., Jones, R.M., Morimoto, C., Leavitt, P. & Barut, B.A. (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood, 73, 1915-1924.
6. Attal, M., Harousseau, J-L., Stoppa, A-M., Sotto, J-J., Fuzibet, J-G., Rossi, J-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New England Journal of Medicine, 335, 91-97.
7. Bataille, R., Barlogie, B., Lu, Z.Y., Rossi, J-F., Lavabre-Bertrand, T., Beck, T., Widjenes, J., Brochier, J. & Klein, B. (1995) Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma. Blood, 86, 685-691.
8. Bergsagel, D.E. (1989) Is aggressive chemotherapy more effective in treatment of plasma cell myeloma? European Journal of Haematology. Suppl. 51, 117-123.
9. Chen, Y-H., Desai, P., Shiao, R-T., Lavelle, D., Haleem, A. & Chen, J. (1996) Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites. Blood, 87, 314-323.
10. Cheng, A-L., Su, I., Chen, C-C., Tien, H-F., Lay, J-D., Chen, B-R., Pu, Y-S., Hong, R-Y., Shen, M-C., Wang, C-H. & Chen, Y-G. (1994) Use of retinoic acids in the treatment of peripheral T cell lymphoma: a pilot study. Journal of Clinical Oncology, 12, 1185-1192.
11. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid-guanidinium-thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
12. Demartis, A., Bernassola, F., Savino, R., Melino, G. & Ciliberto, G. (1996) Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death. Cancer Research, 56, 4213-4218.
13. Fried, J., Perez, C. & Clarkson, B. (1978) Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Journal of Histochemistry and Cytochemistry, 26, 921-933.
14. Gharton, G., Tura, S., Ljungman, P., Belanger, C., Brandt, L., Cavo, M., Facon, T., Granena, A., Gore, M., Gratwohl, A., Lowenberg, B., Nikoskelainen, J., Reiffers, J.J., Samson, D., Verdonck, L. & Volin, L. (1991) Allogeneic bone marrow transplantation in multiple myeloma. New England Journal of Medicine, 325, 1267-1273.
15. Gregory, W.M., Richards, M.A. & Malpas, J.A. (1992) Combination chemotherapy vs melphalan-prednisone in the treatment of multiple myeloma: an overview of published trials. Journal of Clinical Oncology, 10, 334-342.
16. Hansen, M.B., Nielson, S.E. & Berg, K. (1989) Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Journal of Immunologic Methods, 119, 203-210.
17. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H. & Epstein, J. (1994) IL-6 prevents dexamethasone-induced myeloma cell death. Blood, 84, 3063-3070.
18. Hermann, F., Andreef, M., Gruss, H.J., Brach, M.A., Lubbert, M. & Mertelsmann, R. (1991) Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression. Blood, 78, 2070-2074.
19. 389-IL-6. Protein Engineering, 6, 305-311.
20. Jernberg-Wiklund, H., Pettersson, M., Carlsson, M. & Nilsson, K. (1992) Increase in IL-6 and IL-6 receptor expression in a human myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. Leukemia, 6, 310-321.
21. Joseph, B., Lefebvre, O., Méreau-Richard, C., Danze, P-M., Belin-Plancot, M-T. & Formstecher, P. (1998) Evidence for the involvement of both retinoic acid receptor- and retinoic X receptor-dependent signaling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226. Blood, 91, 2423-2432.
22. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
23. Kawano, M.M., Mihard, K., Huang, N., Tsujimoto, T. & Kuramoto, A. (1995) Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood, 85, 487-494.
24. Klein, B. (1995) Cytokine, cytokine receptors, transduction signals and oncogenes in human multiple myeloma. Seminars in Hematology, 32, 4-19.
25. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood, 73, 517-526.
26. Kreitman, R.H., Siegall, C.B., Fitzgerald, D.J.P., Epstein, J., Barlogie, B. & Pastan, I. (1992) Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma. Blood, 79, 1775-1780.
27. Levy, Y., Labaume, S., Colombel, M. & Brouet, J.C. (1996) Retinoic acid modulates the in vivo and in vitro growth IL-6 autocrine human myeloma cell lines via induction of apoptosis. Clinical and Experimental Immunology 104, 167-172.
28. Levy, Y., Tsapis, A. & Brouet, J.C. (1991) Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. Journal of Clinical Investigation, 88, 696-699.
29. Lokhorst, H.M., Lamme, T., deSmet, M., Klein, S., deWeger, R.A., vanOers, R. & Bloem, A.C. (1994) Primary tumor cell of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269-2277.
30. Lu, Z.Y., Brochier, J., Wijdenes, J., Brailly, H., Bataille, R. & Klein, B. (1992) High amounts of circulating IL-6 in the form of monomeric immune complexes during anti-IL-6 therapy. European Journal of Immunology, 22, 2819-2824.
31. Lutzky, J., Vujicic, M., Yamanashi, D.T. & Bhalla, K. (1993) Antiproliferative effects of ATRA and 9-cis-RA on human lymphoid cell lines. Proceedings of the American Association for Cancer Research, 34, 1738A.
32. Muindi, J., Frankel, S.R., Miller, W.H., Jr., Jakubowski, A., Scheinberg, D.A., Young, C.W., Dmitrovsky, E. & Warrell, R.P., Jr (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma concentrations: implications for relapse and retinoid 'resistance' in patients with acute promyelocytic leukemia. Blood, 79, 299-303.
33. Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T. & Kishimoto, T. (1993) IL-6-induced homodimerization of gp130 and associated activation of a lyrosine kinase. Science, 260, 1808-1810.
34. Musto, P., Fallone, A., Sajeva, M.R., D'Arena, G., Bonini, A. & Carotenuto, M. (1995) All-trans retinoic acid for advanced multiple myeloma. Blood, 85, 3769-3770.
35. Niesvlzky, R., Siege, D.S., Busquets, X., Nichols, G., Muindi, Jr, Warrell, R.P., Jr & Michaeli, J. (1995) Hypercalcaemia and increased serum interleukin-6 levels induced by ATRA in patients with multiple myeloma. British Journal of Haematology, 89, 217-218.
36. Ogata, A., Nishimoto, N., Shima, Y., Yoshizaki, K. & Kishimoto, T. (1994) Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with IL-6 signal transduction. Blood, 84, 3040-3046.
37. Ray, A., LaForge, S. & Sehgal, P.B. (1990) On the mechanism for efficient repression of the IL-6 promoter by glucocorticoids. Molecular and Cellular Biology, 10, 5736-5740.
38. Schwab, G., Siegall, C.B., Aarden, L.A., Neckers, L.M. & Nordan, R.P. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266. Blood, 77, 587-593.
39. Sidell, N., Taga, T., Hirano, T., Kishimoto, T. & Saxon, A. (1991) Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. Journal of Immunology, 146, 3809-3814.
40. Spets, H., Jernberg-Wiklund, H., Sambade, C., Soderberg, O. & Nillson, K. (1997) The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/ HL407L human multiple myeloma cell lines. British Journal of Haematology 98, 126-133.
41. Sporeno, E., Savino, R., Ciapponi, L., Paonessa, G., Cabibbo, A., Lahm, A., Pulkki, K., Sun, R-X., Toniatti, C., Klein, B. & Ciliberto, G. (1996) Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood, 87, 4510-4519.
42. Suzuki, H., Yasukawa, K., Saito, T., Goitsuka, R., Hasegawa, A., Ohsugi, Y. & Kishimoto, T. (1992) Anti-human IL-6 receptor antibody inhibits human myeloma cell growth in vivo. European Journal of Immunology, 22, 1889-1923.
43. Taetle, R., Dos Santos, B., Akamatsu, J-I., Koishihara, Y. & Ohsugi, Y. (1996) Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells. Clinical Cancer Research, 2, 253-259.
44. Taetle, R., Dos Santos, B., Ohsugi, Y., Koishihara, Y., Messner, H. & Dalton, W. (1994) Effects of combined antigrowth factor receptor treatment on in vitro growth of multiple myeloma. Journal of the National Cancer Institute, 86, 450-455.
45. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T. & Kishimoto, T. (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell, 58, 573-581.
46. Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, M., Davis,. S., Shoyab, M., Yancopoulos, G.D. & Kishimoto, T. (1992) Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin-6 signal transducer gp130. Proceedings of the National Academy of Sciences of the United States of America, 89, 10998-11001.
47. Uchiyama, H., Barut, B.A., Mohrbacher, A.F., Chauhan, D. & Anderson, K.C. (1993) Adhesion of human myeloma-derived cell lines to bone marrow stromal cell stimulates interleukin-6 secretion. Blood, 82, 3712-3720.
48. Urashima, M., Teoh, G., Chauhan, D., Hoshi, Y., Ogata, A., Treon, S.P., Schlossman, R.L. & Anderson, K.C. (1997) Interleukin 6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells. Blood, 90, 279-289.
49. Vesole, D., Kornbluth, J., Jagannath, S., Sznol, M., Mattox, S., Vaught, L., Tricot, G. & Barlogie, B. (1993) Biological response modifiers in refractory MM: lack of clinical efficacy of rhIL-4 and ATRA. Blood, 82, (Suppl. 1), 1037A.
50. Vesole, D.H., Jagannath, S., Tricot, G., Desikan, K.R., Siegel, D. & Barlogie, B. (1996) Autologous bone marrow and peripheral blood stem cell transplantation in multiple myeloma. Cancer Investigation, 14, 378-391.
51. Zhang, X.G., Klein, B. & Bataille, R. (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with multiple myeloma. Blood, 7, 11-13.